Supplements and Featured Publications
Clinical and Managed Care Implications of Biosimilars: Evaluating the Science and Challenges to Upta
Volume: 21
Issue: 16 Suppl
![Special Issue: Product Pipeline Review [December 2015]](https://cdn.sanity.io/images/0vv8moc6/ajmc/c86b6a1c18f56c6ad4f34612482390855275bf2f-1675x2156.jpg?w=230&fit=crop&auto=format)
Special Issue: Product Pipeline Review [December 2015]
Volume: 21
NAMCP 2015 Conference Coverage
Volume: 21
The Burden of Hyperkalemia in Patients With Cardiovascular and Renal Disease
Volume: 21
Issue: 15 Suppl
Keeping Pace With the Evolving Treatment Landscape in Idiopathic Pulmonary Fibrosis
Volume: 21
Issue: 14
Understanding the Diagnosis, Management, and Treatment Options for Neurogenic Orthostatic Hypoten
Volume: 21
Issue: 13
Management of Advanced/Metastatic Melanoma: New and Emerging Treatment Pathways, Therapies, and Chal
Volume: 21
Issue: 12 Suppl
Evaluation of the Treatment Gap Between Clinical Guidelines and the Utilization of Renin-Angiotensin
Volume: 21
Issue: 11 Suppl
Use of Opioid Analgesics in Managed Care Practice: Challenges, Controversies, REMS, and Optimizing P
Volume: 21
Issue: 9 Suppl
Parkinson’s Disease Psychosis: Symptoms, Management, and Economic Burden
Volume: 21
Issue: 10 Suppl
The Evolving Treatment Landscape and Innovative Payment Models in Oncology: An Expert Summit
Reductions in Mortality Among Medicare Beneficiaries Following the Implementation of Medicare Part D
Volume: 21
Issue: 9 Suppl
Combination Therapy in Pulmonary Arterial Hypertension: Is This the New Standard of Care?
Volume: 21
Issue: 8 Suppl
ADA 2015 Conference Coverage
![Special Issue: Product Pipeline Review [June]](https://cdn.sanity.io/images/0vv8moc6/ajmc/eeaf31968f6213cadba3d4100dae372938facbce-3347x4569.png?w=230&fit=crop&auto=format)
Special Issue: Product Pipeline Review [June]
Volume: 21
The Evidence Behind the Evidence: A Deeper Dive Into the Management of Chronic Heart Failure
Emerging Evidence in NSAID Pharmacology: Important Considerations for Product Selection
Volume: 21
Issue: 7 Suppl
![Hemophilia: Managing the Cost of Care With a Focus on Patient Outcomes [CME/CPE]](https://cdn.sanity.io/images/0vv8moc6/ajmc/05019000301109976bb5bd6b274a4f5482f94f89-900x1229.jpg?w=230&fit=crop&auto=format)
Hemophilia: Managing the Cost of Care With a Focus on Patient Outcomes [CME/CPE]
Volume: 21
Issue: 6 Suppl
Revolutionizing Treatment Outcomes in Hepatitis C: Managed Care Implications and Considerations [CME
Volume: 21
Issue: 5 Suppl
Economic Evaluation of a Fluocinolone Acetonide Intravitreal Implant for Patients With DME Based on
Volume: 21
Issue: 4 Suppl
Characterizing Pulmonary Hypertension–Related Hospitalization Costs Among Medicare Advantage or Co
Volume: 21
Issue: 3 Suppl
Standards of Care Issues With Anticoagulation in Real-World Populations
Volume: 21
Issue: 2 Suppl
![Managed Care’s Role in Improving Adherence and Outcomes in Solid Organ Transplantation [CME/CPE]](https://cdn.sanity.io/images/0vv8moc6/ajmc/371bb77085a8399820783447221ceeedad255a69-900x1229.jpg?w=230&fit=crop&auto=format)
Managed Care’s Role in Improving Adherence and Outcomes in Solid Organ Transplantation [CME/CPE]
Volume: 21
Issue: 1 Suppl
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
5 Things to Know About the Oral GLP-1 Era
5
